RYZB News
Archived Headlines
- Radiopharmaceutical biotech RayzeBio prices upsized IPO at $18, the high end of the range 09/15/23
- Radiopharmaceutical biotech RayzeBio sets terms for $245 million IPO 09/11/23
- US IPO Week Ahead: Arm set to test the IPO market with biggest listing in nearly two years 09/08/23
- US IPO Weekly Recap: September IPO roster gets a boost as Arm, Instacart, and other large filers join the pipeline 08/25/23
- US IPO Week Ahead: Quiet August wraps with holdover biotech Adlai Nortye, as big deals prep September IPOs 08/25/23
See more
Here's what the top-performing IPOs of 2023 tell us about 2024
Get ready for a bevy of biotech IPOs. The 30 IPOs that raised $100 million or more in 2023 currently average a strong 25% return from offer, thanks to solid first day gains (+14%) that have built in the aftermarket (+9%). ...read more
Pessimism over Fed policy and geopolitical tensions topple year's large IPOs; here are the deals that have weathered the recent turmoil
After a strong rally through July, markets have treaded water for the past three months as investors grow pessimistic about the possibility of near-term rate cuts, against a backdrop of political gridlock in the US and a new war abroad. The year's sizable IPOs...read more
Updated: Renaissance Capital's 3Q 2023 US IPO Market Review
Large Tech IPOs Stage a Comeback in a Volatile 3Q The third quarter of 2023 produced 30 IPOs that raised a combined $7.8 billion, more than the proceeds raised in the full-year 2022 despite no...read more
US IPO Weekly Recap: Arm trades up after raising nearly $5 billion in 2023’s largest IPO to date
Five IPOs raised a combined $5.4 billion this past week, led by the blockbuster IPO of Arm (ARM). Three issuers submitted initial filings. The largest IPO of 2023 so far, Arm priced at the top of the range to raise $4.9...read more